Bachem Holding AG

Research Bachem Holding AG (BANB) on Bullrun: market cap CHF 5.01B, P/E 33.8, dividend yield 1.3%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerBANB
• ExchangeSW
• CountrySwitzerland
• SectorHealthcare
• IndustryBiotechnology
• CurrencyCHF
• Market capCHF 5.01B
• P/E33.8
• Dividend yield1.3%
• Financial periodFY2025
• RevenueCHF 695.07M
• Revenue growth14.8%
• Net incomeCHF 148.79M
• Free cash flow-CHF 57.82M
• Gross margin28.7%

Valuation Snapshot

latest market cap is CHF 5.01B; P/E is 33.8; dividend yield is 1.3%.

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics;

Frequently asked questions

What is Bachem Holding AG's market cap?

Bachem Holding AG's market capitalization is CHF 5.01B.

What is Bachem Holding AG's P/E ratio?

Bachem Holding AG's price-to-earnings (P/E) ratio is 33.8.

Does Bachem Holding AG pay a dividend?

Bachem Holding AG has a dividend yield of 1.3%.

What does Bachem Holding AG do?

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.